NRC Q1 2025 10-Q Filing

Ticker: NRC · Form: 10-Q · Filed: May 9, 2025 · CIK: 70487

National Research CORP 10-Q Filing Summary
FieldDetail
CompanyNational Research CORP (NRC)
Form Type10-Q
Filed DateMay 9, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, quarterly-report, financials

TL;DR

NRC Q1 2025 10-Q filed. Financials and operations update.

AI Summary

National Research Corporation (NRC) filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational aspects for the first quarter of 2025. NRC's primary business involves providing research and consulting services, particularly within the healthcare sector, focusing on customer experience and market insights.

Why It Matters

This filing provides investors with a quarterly update on National Research Corporation's financial health and strategic direction, crucial for understanding its performance in the competitive research and consulting market.

Risk Assessment

Risk Level: low — The filing is a standard quarterly report and does not indicate any immediate or significant new risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of National Research Corporation?

National Research Corporation is primarily engaged in the Services-Commercial Physical & Biological Research sector, SIC code 8731, focusing on research and consulting.

What is the filing date of this 10-Q?

This 10-Q filing was made on May 9, 2025.

What period does this 10-Q report cover?

This 10-Q report covers the period ending March 31, 2025.

What is the Central Index Key (CIK) for National Research Corporation?

The CIK for National Research Corporation is 0000070487.

Where is National Research Corporation headquartered?

National Research Corporation is headquartered in Lincoln, Nebraska, with its business address at 1245 Q Street, Lincoln, NE 68508.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 9, 2025 regarding NATIONAL RESEARCH CORP (NRC).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing